You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Asclemed USA Inc.FDAMed source confidence · 80%Jun 22, 2026, 6:17 PM UTC · 15d ago
Asclemed USA Inc. — FDA Class II (D-0555-2026)
Case File
Asclemed USA Inc. is recalling 50 bottles of a human prescription drug due to CGMP deviations involving Nitrosamine contamination. This recall is classified as a safety issue. The specific lot numbers affected are 76420-623, 76420-633, 76420-634, and 76420-636.
•Asclemed USA Inc. is recalling 50 bottles of a human prescription drug.
•The recall is due to Nitrosamine contamination.
•Affected lot numbers include 76420-623, 76420-633, 76420-634, and 76420-636.
•Patients should stop using these products immediately.
•Recalls like this are typically viewed as a negative event for the company involved.
Why This Matters
Patients using the recalled drugs should stop using them due to potential health risks from Nitrosamine contamination. The recall affects 50 bottles, which could impact users' health.